Skip to main content
SpringerLink
Log in

Antioxidant Treatment of Ischemic Brain Lesions

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. V. S. Vilenskii and I. I. Anosov, Stroke [in Russian], Meditsina, Leningrad (1980).

    Google Scholar 

  2. E. I. Gusev,V. I. Skvortsova, and L. V. Stakhovskaya, “Epidemiology of stroke in Russia,” Zh. Nevrol. Psikhiat., 9, Stroke Suppl., 114 (2003).

    Google Scholar 

  3. E. I. Gusev, “The problem of stroke in Russia,” Zh. Nevrol. Psikhiat., 9, Stroke Suppl., 3–5 (2003).

  4. V. I. Gusev and V. I. Skvortsova, Cerebral Ischemia [in Russian], Meditsina, Moscow (2001).

    Google Scholar 

  5. S. G. Burchinskii, “Current approaches to neuroprotection,” Novosti Med. Farm., No. 10–11, 6–7 (2004).

  6. S. G. Burchinskii, “Neuroprotective pharmacology in geriatrics: protection of what for what,” Zdorovya Ukraini, 8, 42–43 (2006).

    Google Scholar 

  7. E. V. Verizhnikova, I. S. Petrusenko, and I. I. Sholomov, “Current aspects of cytoprotective correction and neuroresuscitation. Clinical pharmacology,” Byull. Eksperim. Biol. Med., No. 1, 14–17 (2005).

    Google Scholar 

  8. S. A. Rumyantseva,V. A. Stupin,V. V. Afanasiev, et al., Critical States in Clinical Practice [in Russian], Medical Books Int. Publ. Group (Meditsinskaya Kniga) (2011).

  9. V. I. Skvortsova, “Treatment of acute ischemic stroke,” Neotlozh. Terapiya, No. 1–2, 20–24 (2005).

  10. S. M. Vinichuk, “Oxidative stress in acute ischemic stroke and its correction with the antioxidant Mexidol,” Mezhdunarod. Nevrol. Zh., 4, 45–52 106

  11. V. M. Vinogradov and B. I. Krivoruchko, “Pharmacological protection of the brain from hypoxia,” Psikhofarmakol. Biol. Narkol., No. 1, 27–37 (2001).

  12. T. A. Voronina, Mexidol: Main Effects, Mechanism of Action, Use. Guidelines [in Russian] (2000).

  13. T. A. Voronina, “The antioxidant Mexidol. Main neuropsychotropic effects and mechanisms of action,” Psikhofarmakol. Biol. Narkol., No. 1, 2–12 (2001).

  14. T. A. Voronina, Mexidol: Main Effects, Mechanism of Action, Use [in Russian], Kazan (2004).

  15. K. M. Dyumaev, T. A. Voronina, and L. D. Smirnov, Antioxidants in the Prophylaxis and Treatment of CNS Pathologies [in Russian], Moscow (1995).

  16. M. A. Lutskii, “Oxidative stress and treatment with antioxidants,” Nerv. Bolezn., No. 3, 15–20 (2007).

  17. V. I. Skvortsova, L. V. Stakhovskaya,Ya. R. Nartsissov, et al., “A randomized double-blind, placebo-controlled study of the efficacy and safety of Mexidol in the complex treatment of ischemic stroke in the acute period,” Zh. Nevrol. Psikhiat., 9, Stroke Suppl., 18 (2006).

  18. Z. A. Suslina, T. N. Fedorova, M. Yu. Maksimova, et al., “Antioxidant treatment in ischemic stroke,” Zh. Nevrol. Psikhiat., No. 10, 34–38 (2000).

    Google Scholar 

  19. A. I. Fedin, S. A. Rumyantseva, O. P. Mironova, and V. N. Evseev, The Use of the Antioxidant Mexidol in Patients with Acute Cerebral Circulatory Lesions. Guidelines [in Russian], (2000).

  20. D. V. Sadchikov, T. N. Kulikova, I. V. Lopatin, et al., Mexidol in the Treatment of Critical States [in Russian], Saratov (2005).

  21. A. L. Shevchenko, “On the question of the therapeutic activity of Mexidol in the treatment of patients with ischemic strokes,” Mezhdunar. Nevrol. Zh., No. 6, 87–93 (2006).

    Google Scholar 

  22. T. A. Puzyreva, “The use of Mexidol in acute and chronic cerebrovascular diseases,” Nevrol. Psikhiat., No. 2, 27–30 (2004).

  23. D. V. Sadchikov, T. N. Kulikova, I. V. Lopatin, and A. D. Zhiltsov, The Use of Mexidol in Critical States. Guidelines [in Russian], Moscow (2002).

  24. G. I. Klebanov, O. B. Lyubitskii, O. V. Vasilieva, et al., “The antioxidant properties of 3-hydroxypyridine: Mexidol, emoxypine, and Proxipine,” Vopr. Med. Khimii, No. 3, 45–51 (2001).

  25. S. M. Kuznetsova, “Mexidol in the rehabilitation of elderly patients with stroke,” Ukr. Nevrol. Zh., No. 3, 77–81 (2007).

    Google Scholar 

  26. V. E. Novikov, L. A. Kovaleva, S. O. Losenkova, et al., “The pharmacology of antioxidants based on hydroxypyridine,” Vestn. Smolenskoi Med. Akad., No. 1, 23–42 (2004).

    Google Scholar 

  27. I. S. Pavlov and L. A. Medvedeva, Mexidol in the Clinical Practice of Borderline Psychiatry [in Russian], Kazan, (2004).

  28. N. V. Mironov, V. V. Sudneva, and I. I. Goryainova, “The use of Mexidol in the complex treatment of patients with ischemic stroke during the recovery period,” Kremlev. Med., No. 2, 27–29 (2001).

    Google Scholar 

  29. T. V. Ostrovaya, V. I. Chernii, G. A. Gorodnik, et al., “A trial of the effects of Mexidol on the functional state of the CNS in patients with ischemic stroke,” Mezhdunarod. Nevrol. Zh., No. 4, 51–56 (2005).

    Google Scholar 

  30. L. A. Medvedeva, “The use of Mexidol in the treatment of dyscirculatory encephalopathies,” Nevrol. Psikhiat., No. 4, 38–41 (2002).

  31. D. V. Kandyba, N. M. Zhulev, G. Yu. Sokurenko, and O. S. Markova, “The use of Mexidol in the complex conservative and angiocorrective treatment of ischemic cerebral circulatory impairments of extracranial origin,” Zh. Farmateka, No. 7, 25–30, (2006).

    Google Scholar 

  32. S. Z. Umarov, “Pharmacoeconomic analysis of the medication therapy of cerebral circulatory impairments,” Zh. Farmateka, No. 5, 67–70 (2006).

Download references

Author information

Authors and Affiliations

  1. Russian State Medical Institute, Moscow, Russia

    S. A. Rumyantseva, A. I. Fedin & O. N. Sokhova

Authors
  1. S. A. Rumyantseva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. I. Fedin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. N. Sokhova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. A. Rumyantseva.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 111, No. 4, Iss. 2, Stroke, pp. 28–31, April, 2011.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rumyantseva, S.A., Fedin, A.I. & Sokhova, O.N. Antioxidant Treatment of Ischemic Brain Lesions. Neurosci Behav Physi 42, 842–845 (2012). https://doi.org/10.1007/s11055-012-9646-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-012-9646-3

Keywords

Search

Navigation